Immucell Corp (ICCC) Stock Price, Quote & News

Company Profile

ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It operates through two segments: Scours and Mastitis. The company offers First Defense, an orally delivered scours preventive product for calves with claims against E. coli, coronavirus, and rotavirus; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus...

Industry: Biotechnology

Sector: Healthcare

Phone: 207 878 2770

Website: immucell.com

Address:

56 Evergreen Drive, Portland, United States

TommyTwenty Sep. 29 at 8:59 PM

$ICCC new ceo is a partner at a global investment firm focused on helping scale animal healthcare solutions. Also a history of M&A.

0 · Reply

theRooster007 Sep. 29 at 8:18 PM

$ICCC https://lifesciencereport.com/news/nasdaq/iccc/immucell-announces-selection-of-its-next-president-and-ceo

0 · Reply

MilagrosGrosse283 Sep. 22 at 8:20 AM

$ICCC Technology services growth. Testing resistance level. Volume confirmation needed. Sector momentum.

1 · Reply

RiverOfReturns Aug. 27 at 9:30 AM

$ICCC testing resistance, potential breakout if volume sustains.

0 · Reply

ZacksResearch Aug. 21 at 3:53 PM

$ICCC shares dropped 7.4% post-earnings — what's behind the decline? 📉 Despite an 18% revenue increase and net income swinging to a profit, investor caution lingers due to temporary sales boosts from distributor restocking and Re-Tain's regulatory hurdles. ⚠️ Understand the full story here 👉 https://www.zacks.com/stock/news/2740928/immucell-swings-to-q2-profit-on-strong-sales-shares-still-slide?cid=sm-stocktwits-2-2740928-body-8846&ADID=SYND_STOCKTWITS_TWEET_2_2740928_BODY_8846

0 · Reply

ZacksResearch Aug. 21 at 2:53 PM

$ICCC posted a profit… but the stock sold off anyway. ⚠️ Stronger sales drove a Q2 swing to profit, yet shares still slid — a disconnect that investors can’t ignore. Full breakdown here 👉 https://www.zacks.com/stock/news/2740928/immucell-swings-to-q2-profit-on-strong-sales-shares-still-slide?cid=sm-stocktwits-2-2740928-teaser-8835&ADID=SYND_STOCKTWITS_TWEET_2_2740928_TEASER_8835

0 · Reply

d_risk Aug. 17 at 4:29 PM

$ICCC - IMMUCELL CORP /DE/ - 10Q - Updated Risk Factors ICCC’s updated risks highlight new funding and regulatory hurdles for Re-Tain, expanded concerns over market acceptance, premium pricing, customer retention, and distributor concentration, plus ongoing production, liability, and inspection risks for both Re-Tain and First Defense. #Biotechnology #DistributorConcentration #ProductLiability #MarketAcceptance #RegulatoryRisk 🟢 Added 🟠 Removed https://d-risk.ai/ICCC/10-Q/2025-08-14

0 · Reply

TommyTwenty Aug. 15 at 4:38 AM

$ICCC

1 · Reply

theRooster007 Aug. 14 at 8:10 PM

$ICCC https://www.stocktitan.net/news/ICCC/immu-cell-announces-unaudited-financial-results-for-the-quarter-w3ov2mpe46qj.html

0 · Reply

TommyTwenty Aug. 12 at 9:15 PM

$ICCC https://www.stocktitan.net/news/ICCC/immu-cell-announces-bank-debt-jkww9k3dsyg9.html

0 · Reply

ImmuCell Announces Selection of its Next President and CEO

Aug 15, 2025, 11:04 AM EDT - 7 weeks ago

ImmuCell Corporation (ICCC) Q2 2025 Earnings Call Transcript

Aug 14, 2025, 4:05 PM EDT - 7 weeks ago

ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2025

Aug 12, 2025, 4:05 PM EDT - 7 weeks ago

ImmuCell Announces Bank Debt Refinancing

Aug 7, 2025, 8:00 AM EDT - 2 months ago

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2025

Jul 9, 2025, 8:00 AM EDT - 3 months ago

ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 of 2025

Jun 25, 2025, 8:00 AM EDT - 3 months ago

ImmuCell Embarks on CEO Succession Planning Process

Jun 5, 2025, 6:30 AM EDT - 4 months ago

ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders

May 15, 2025, 10:19 AM EDT - 5 months ago

ImmuCell Corporation (ICCC) Q1 2025 Earnings Call Transcript

May 14, 2025, 4:05 PM EDT - 5 months ago

ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2025

May 12, 2025, 8:42 AM EDT - 5 months ago

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2025

Apr 8, 2025, 4:05 PM EDT - 6 months ago

ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 of 2025

Apr 2, 2025, 4:05 PM EDT - 6 months ago

ImmuCell Announces Initiation of Investigational Product Use of Re-Tain®

Feb 26, 2025, 11:44 AM EST - 7 months ago

ImmuCell Corporation (ICCC) Q4 2024 Earnings Call Transcript

Feb 25, 2025, 4:05 PM EST - 7 months ago

ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2024

Feb 20, 2025, 8:19 AM EST - 8 months ago

ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2024

Jan 16, 2025, 4:05 PM EST - 9 months ago

ImmuCell Announces Settlement of Insurance Claim Related to Previously Disclosed Production Contamination Losses

Jan 9, 2025, 4:05 PM EST - 9 months ago

ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year 2024

Nov 14, 2024, 11:09 AM EST - 11 months ago

ImmuCell Corporation (ICCC) Q3 2024 Earnings Call Transcript

Nov 13, 2024, 4:05 PM EST - 11 months ago

ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2024

Nov 7, 2024, 8:30 AM EST - 11 months ago

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2024

Oct 8, 2024, 4:05 PM EDT - 1 year ago

ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2024

Aug 14, 2024, 12:18 PM EDT - 1 year ago

ImmuCell Corporation (ICCC) Q2 2024 Earnings Call Transcript

Aug 13, 2024, 4:05 PM EDT - 1 year ago

ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2024

Aug 7, 2024, 4:05 PM EDT - 1 year ago

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2024

Jul 9, 2024, 4:05 PM EDT - 1 year ago

ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 2024

Jun 5, 2024, 4:05 PM EDT - 1 year ago

ImmuCell Provides Update on Regulatory Status of Product Development Initiative for Re-Tain®

May 15, 2024, 1:48 PM EDT - 1 year ago

ImmuCell Corporation (ICCC) Q1 2024 Earnings Call Transcript

May 14, 2024, 4:05 PM EDT - 1 year ago

ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2024

May 8, 2024, 1:00 PM EDT - 1 year ago

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2024

Apr 9, 2024, 4:05 PM EDT - 1 year ago

ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2024

Feb 28, 2024, 11:58 AM EST - 1 year ago

ImmuCell Corporation (ICCC) Q4 2023 Earnings Call Transcript

Feb 27, 2024, 4:05 PM EST - 1 year ago

ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2023

Feb 16, 2024, 9:30 AM EST - 1 year ago

ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2023

Jan 8, 2024, 4:05 PM EST - 1 year ago

ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 2023

Nov 14, 2023, 2:36 PM EST - 2 years ago

ImmuCell Corporation (ICCC) Q3 2023 Earnings Call Transcript

Nov 13, 2023, 4:05 PM EST - 2 years ago

ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2023

Nov 7, 2023, 12:15 PM EST - 2 years ago

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2023

Oct 5, 2023, 4:05 PM EDT - 2 years ago

ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2023

Aug 29, 2023, 8:00 AM EDT - 2 years ago

ImmuCell Announces Submission of CMC Technical Section to the FDA

Aug 11, 2023, 4:48 PM EDT - 2 years ago

ImmuCell Corporation (ICCC) Q2 2023 Earnings Call Transcript

Aug 10, 2023, 4:05 PM EDT - 2 years ago

ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2023

Aug 7, 2023, 12:00 PM EDT - 2 years ago

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2023

Jul 11, 2023, 4:05 PM EDT - 2 years ago

ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 2023

Jun 28, 2023, 4:05 PM EDT - 2 years ago

ImmuCell Announces Change in Timing of Anticipated FDA Submission

Jun 21, 2023, 4:05 PM EDT - 2 years ago

ImmuCell Appoints Bryan K. Gathagan to Board of Directors

Jun 15, 2023, 4:05 PM EDT - 2 years ago

ImmuCell Announces Approval of Principal Terms of a $3 Million Debt Facility

May 12, 2023, 10:00 AM EDT - 2 years ago

ImmuCell Corporation (ICCC) Q1 2023 Earnings Call Transcript

May 11, 2023, 4:05 PM EDT - 2 years ago

ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2023

May 4, 2023, 6:30 AM EDT - 2 years ago

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2023

TommyTwenty Sep. 29 at 8:59 PM

$ICCC new ceo is a partner at a global investment firm focused on helping scale animal healthcare solutions. Also a history of M&A.

0 · Reply

theRooster007 Sep. 29 at 8:18 PM

$ICCC https://lifesciencereport.com/news/nasdaq/iccc/immucell-announces-selection-of-its-next-president-and-ceo

0 · Reply

MilagrosGrosse283 Sep. 22 at 8:20 AM

$ICCC Technology services growth. Testing resistance level. Volume confirmation needed. Sector momentum.

1 · Reply

RiverOfReturns Aug. 27 at 9:30 AM

$ICCC testing resistance, potential breakout if volume sustains.

0 · Reply

ZacksResearch Aug. 21 at 3:53 PM

0 · Reply

ZacksResearch Aug. 21 at 2:53 PM

0 · Reply

d_risk Aug. 17 at 4:29 PM

0 · Reply

TommyTwenty Aug. 15 at 4:38 AM

$ICCC

1 · Reply

theRooster007 Aug. 14 at 8:10 PM

$ICCC https://www.stocktitan.net/news/ICCC/immu-cell-announces-unaudited-financial-results-for-the-quarter-w3ov2mpe46qj.html

0 · Reply

TommyTwenty Aug. 12 at 9:15 PM

$ICCC https://www.stocktitan.net/news/ICCC/immu-cell-announces-bank-debt-jkww9k3dsyg9.html

0 · Reply

TommyTwenty Aug. 7 at 5:20 PM

$ICCC https://youtu.be/Cd_FI97Tu-Y

0 · Reply

TommyTwenty Jul. 29 at 7:04 PM

$ICCC old article I found. https://www.mainebiz.biz/article/an-industry-with-a-family-tree-much-of-maines-biotech-industry-grew-out-of-two-firms

0 · Reply

TommyTwenty Jul. 29 at 11:58 AM

$ICCC

0 · Reply

NVDAMillionaire Jul. 28 at 7:35 PM

$ICCC Outstanding article that hits the mark on ICCC's current state. So if you want to refresh your ICCC insights or learn about ICCC from scratch, this is a must read. https://beyondspx.com/article/immucell-riding-operational-recovery-and-novel-technology-towards-profitability-iccc

0 · Reply

TagUrIt Jul. 25 at 1:28 PM

$ICCC well the Zach’s announcement should help with the companies visibility…

1 · Reply

ZacksResearch Jul. 22 at 5:58 PM

$ICCC just got a major upgrade — here's why the bulls are circling 🐂 Q1 sales hit record highs, margins expanded, and Re-Tain’s FDA momentum plus new formats are fueling serious upside potential. Full breakdown of the upgrade here 👉 https://www.zacks.com/stock/news/2604144/immucell-upgraded-to-outperform-on-sales-surge-fda-upside?cid=sm-stocktwits-2-2604144-teaser-3177&ADID=SYND_STOCKTWITS_TWEET_2_2604144_TEASER_3177

0 · Reply

ZacksResearch Jul. 22 at 3:56 PM

$ICCC up 64.3% in a year — what's driving the surge? 🚀 📈 Record Q1 sales of $8.1M, up 11% YoY, fueled by strong First Defense demand. 📊 Gross margin jumped to 42% from 32% a year ago, boosting cash flow and liquidity. 🔍 New bulk powder format and the potential of Re-Tain under FDA review offer strategic growth opportunities. See what makes the investment case strong for ImmuCell 👉 https://www.zacks.com/stock/news/2604144/immucell-upgraded-to-outperform-on-sales-surge-fda-upside?cid=sm-stocktwits-2-2604144-body-3098&ADID=SYND_STOCKTWITS_TWEET_2_2604144_BODY_3098

0 · Reply

TommyTwenty Jul. 9 at 2:47 PM

$ICCC looks they’re initiating expansion from 30 mill to 40 mill.

0 · Reply

TommyTwenty Jul. 9 at 1:13 PM

$ICCC backlog has been reduced to under 100k.

0 · Reply

theRooster007 Jul. 9 at 12:41 PM

$ICCC https://lifesciencereport.com/news/nasdaq/iccc/immucell-announces-preliminary-unaudited-sales-results-for-q2-of-2025

0 · Reply

DARKP00L Jul. 9 at 12:13 PM

$ICCC 08:11 on Jul. 09 2025 ImmuCell Announces Prelim. Q2 Sales $6.4M, Up 18% YoY #tradeideas

0 · Reply

TommyTwenty Jul. 2 at 8:19 PM

$ICCC recent selloffs have been low volume.

1 · Reply

Market Cap	57.08M
Revenue (ttm)	26.49M
Net Income (ttm)	-2.16M
EPS (ttm)	N/A
PE Ratio	34.47
Forward PE	N/A
Profit Margin	-8.15%
Debt to Equity Ratio	0.33

Volume	5,980
Avg Vol	11,772
Day's Range	N/A - N/A
Shares Out	9.05M
Stochastic %K	50%
Beta	0.30
Analysts	Strong Buy
Price Target	$14.00